Abeona Therapeutics ABEO
NASDAQ ABEO
$5.03 +0.02 (+0.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Abeona Therapeutics (ABEO) Asset Writedowns and Impairment (2022)

Updated

Abeona Therapeutics (ABEO) posted Asset Writedowns and Impairment of -$1.07 million for FY2023, compared with $2.51 million in FY2022.

Analysis

Abeona Therapeutics (ABEO) Asset Writedowns and Impairment (2022) Analysis & Trends

  • Business Quant data shows ABEO's Asset Writedowns and Impairment at $2.51 million in FY2022 (-92.3%) and $32.5 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Abeona Therapeutics 287.85 Mn -426.11 Mn 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 711,000.00
Jun 30, 2022 -1.50 Mn
Mar 31, 2022 3.30 Mn
API Access

Abeona Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ABEO&period=max&api_key=YOUR_API_KEY